Sponsor or institution
Clinical trials and research at Evoq Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $3.7 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
NanoDiscs: a new way to calm the immune system in celiac disease
A new, protein-like particle called NanoDiscs is being developed to deliver safe targets to the immune system in people with celiac disease, with the goal of reducing reactions to gluten.
-
New Treatment for MOG Antibody Condition
This research is developing a new, targeted treatment for people living with MOG antibody disease, a rare neurological condition.
-
New treatment for MOG antibody disease using nanoparticles
This study is testing a new treatment for MOG antibody disease that uses tiny particles to help your immune system learn to tolerate the disease better, with the hope of providing a safer option than current medications like steroids.
-
New method to modulate the immune system for Type 1 diabetes
This study is testing a new treatment for Type 1 diabetes that aims to help your immune system work better by encouraging the growth of special cells that can protect your insulin-producing cells, using a unique delivery method to make it safe and effective for people with T1D.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.